PlantPharm BioMed Ltd. © 2018 - All rights reserved.

How We Can Assist You

PlantPharm BioMed's mission is to extend the pharmaceutical industry’s market reach and patent protection by converting their current products into plant-grown biopharmaceuticals.  We will do this by partnering with you to convert your current vaccine, monoclonal antibody, protein or peptide into a plant-grown version.

I believe for vaccines, this will result in an oral dose extending your market reach into previously inaccessible locations and increasing vaccine efficacy.  For other biopharmaceuticals, I believe our plant production platform will reduce your costs, extend patent protection and improve your safety profile.

I invite you to sit down with us to discuss how we can partner together to accomplish these goals with a plant-grown production platform.

Richard R. Matner, Ph.D., MBA

President & Chief Strategy Officer

PlantPharm BioMed, Ltd.

Contact me: